Skip to content
MarketScale
‹ Back to IndustriesHealthcare

A Test for Our Time: Crisis Leadership in the Next Normal

Leadership isn’t all glitz and glam. It’s a grind, and leaders need to know how to handle themselves and their teams in all situations, including crises. Communication, adaptability, proactiveness, and empathy are just some of the characteristics needed for effective crisis leadership. But how did leaders like Dr. Stephen Tang, a CEO in the life…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Holistic Leadership on MarketScale.

Share

Leadership isn’t all glitz and glam. It’s a grind, and leaders need to know how to handle themselves and their teams in all situations, including crises. Communication, adaptability, proactiveness, and empathy are just some of the characteristics needed for effective crisis leadership.

But how did leaders like Dr. Stephen Tang, a CEO in the life sciences industry, handle such a profound and long-lasting crisis like the COVID-19 pandemic?

On today’s episode of Holistic Leadership, Hosts Travis Hearne and Geoffrey Roche speak with Dr. Stephen Tang, CEO, Entrepreneur, Civic Leader, and Author of A Test for Our Time: Crisis Leadership in the Next Normal. Hearne and Dr. Tang work through his crisis leadership as CEO of OraSure Technologies during the pandemic, what he believes contributes to wholehearted leadership, and the driving forces behind his authorship.

Authenticity is one the characteristics that builds a great leader, and Dr. Tang knows and lives this. When leaders hold true to their values and personalities while displaying honesty, it makes it easier for their team to trust them.

Dr. Tang shared, “I think what I learned from it was this notion in the book of wholehearted leadership, which is, you really do need to be present for your people, be authentic for your people, communicate to them in a way that they can understand that you understand the tragedy of the situation and the optimism of the situation. And thoroughly care for them not just because they’re doing work for you day in, day out, but because they’re whole people with whole, full lives themselves.”

Hearne, and Dr. Tang also discussed…

  1. The reasons Dr. Tang decided to author his book
  2. Tang’s experience as OraSure CEO during COVID-19 and advice for leaders walking through crises
  3. How to encourage leaders to take risks during crises

“Leaders have to earn their trust every single day. So, to present yourself as credible and intimate with your people I think is vitally important. And I go back to something that I said before. What does wholehearted mean? Wholehearted means nurturing the mind, body, and spirit unashamedly…It’s truly caring about all those dimensions,” Dr. Tang explained.

Dr. Stephen Tang is CEO, Entrepreneur, Civic Leader, and Author of A Test for Our Time: Crisis Leadership in the Next Normal. Dr. Tang has been CEO of OraSure Technologies since 2011 and has served as Chairman and Member of many Boards of Directors throughout his career. Dr. Tang earned his BS in Chemistry from The College of William & Mary, his MS and Ph.D. in Chemical Engineering from LeHigh University, and his MBA in Strategy, Finance, & Entrepreneurship from The Wharton School.

Holistic Leadership

Part of this channel

Holistic Leadership

Healthcare leadership grounded in culture, well-being, and practical growth.

Visit the channel

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

The Centers for Medicare & Medicaid Services (CMS) has established the Office of Health Technology and Products to integrate AI, interoperability, and digital strategies. This new office aims to enhance efficiency across Medicare, Medicaid, and CHIP programs. By centralizing these efforts, CMS seeks to improve healthcare delivery and outcomes.

  • 01The CMS has launched a new office focusing on AI and interoperability.
  • 02The Office of Health Technology and Products will support Medicare, Medicaid, and CHIP programs.
  • 03Centralizing digital strategies aims to improve healthcare delivery and outcomes.

Aug 1, 2026

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

The Centers for Medicare & Medicaid Services (CMS) has established a new Office of Health Technology and Products. This office assumes over 90 responsibilities to lead federal health IT strategy, focusing on areas like AI, interoperability, and claims modernization.

  • 01CMS's new office centralizes health tech authority, focusing on AI and interoperability.
  • 02The office takes on over 90 responsibilities to modernize claims processes.
  • 03CMS aims to lead federal health IT strategy with its new dedicated office.

Aug 1, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512